Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus

MLA

Sten Madsbad, et al. “Inappropriate Suppression of Glucagon during OGTT but Not during Isoglycaemic i.v. Glucose Infusion Contributes to the Reduced Incretin Effect in Type 2 Diabetes Mellitus.” Diabetologia, vol. 50, no. 4, Sept. 2006. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5af04a3fd9a2d00212384b1d1aa30ef8&authtype=sso&custid=ns315887.

APA

Sten Madsbad, Tina Vilsbøll, Thure Krarup, Filip K. Knop, & J. J. Holst. (2006). Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus. Diabetologia, 50(4).

Chicago

Sten Madsbad, Tina Vilsbøll, Thure Krarup, Filip K. Knop, and J. J. Holst. 2006. “Inappropriate Suppression of Glucagon during OGTT but Not during Isoglycaemic i.v. Glucose Infusion Contributes to the Reduced Incretin Effect in Type 2 Diabetes Mellitus.” Diabetologia 50 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5af04a3fd9a2d00212384b1d1aa30ef8&authtype=sso&custid=ns315887.